Global Metacycline Market Growth 2025-2031

October 2025 | 78 pages | ID: G570BCA102F9EN
LP Information

Abstracts

The global Metacycline market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Metacycline is a tetracycline antibiotic. It is used as a precursor in the industrial synthesis of doxycycline hyclate.

United States market for Metacycline is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Metacycline is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Metacycline is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Metacycline players cover Merck, Boc Sciences, Manus Aktteva Biopharma, Cayman Chemical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Metacycline Industry Forecast” looks at past sales and reviews total world Metacycline sales in 2024, providing a comprehensive analysis by region and market sector of projected Metacycline sales for 2025 through 2031. With Metacycline sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Metacycline industry.

This Insight Report provides a comprehensive analysis of the global Metacycline landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Metacycline portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Metacycline market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Metacycline and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Metacycline.

This report presents a comprehensive overview, market shares, and growth opportunities of Metacycline market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Chronic Bronchitis
• Rickettsial Infections
• Others

Segmentation by Application:

• Clinics
• Hospitals

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Merck
• Boc Sciences
• Manus Aktteva Biopharma
• Cayman Chemical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Metacycline market?
What factors are driving Metacycline market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Metacycline market opportunities vary by end market size?
How does Metacycline break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Metacycline Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Metacycline by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Metacycline by Country/Region, 2020, 2024 & 2031
2.2 Metacycline Segment by Type
  2.2.1 Chronic Bronchitis
  2.2.2 Rickettsial Infections
  2.2.3 Others
2.3 Metacycline Sales by Type
  2.3.1 Global Metacycline Sales Market Share by Type (2020-2025)
  2.3.2 Global Metacycline Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Metacycline Sale Price by Type (2020-2025)
2.4 Metacycline Segment by Application
  2.4.1 Clinics
  2.4.2 Hospitals
2.5 Metacycline Sales by Application
  2.5.1 Global Metacycline Sale Market Share by Application (2020-2025)
  2.5.2 Global Metacycline Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Metacycline Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Metacycline Breakdown Data by Company
  3.1.1 Global Metacycline Annual Sales by Company (2020-2025)
  3.1.2 Global Metacycline Sales Market Share by Company (2020-2025)
3.2 Global Metacycline Annual Revenue by Company (2020-2025)
  3.2.1 Global Metacycline Revenue by Company (2020-2025)
  3.2.2 Global Metacycline Revenue Market Share by Company (2020-2025)
3.3 Global Metacycline Sale Price by Company
3.4 Key Manufacturers Metacycline Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Metacycline Product Location Distribution
  3.4.2 Players Metacycline Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR METACYCLINE BY GEOGRAPHIC REGION

4.1 World Historic Metacycline Market Size by Geographic Region (2020-2025)
  4.1.1 Global Metacycline Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Metacycline Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Metacycline Market Size by Country/Region (2020-2025)
  4.2.1 Global Metacycline Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Metacycline Annual Revenue by Country/Region (2020-2025)
4.3 Americas Metacycline Sales Growth
4.4 APAC Metacycline Sales Growth
4.5 Europe Metacycline Sales Growth
4.6 Middle East & Africa Metacycline Sales Growth

5 AMERICAS

5.1 Americas Metacycline Sales by Country
  5.1.1 Americas Metacycline Sales by Country (2020-2025)
  5.1.2 Americas Metacycline Revenue by Country (2020-2025)
5.2 Americas Metacycline Sales by Type (2020-2025)
5.3 Americas Metacycline Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Metacycline Sales by Region
  6.1.1 APAC Metacycline Sales by Region (2020-2025)
  6.1.2 APAC Metacycline Revenue by Region (2020-2025)
6.2 APAC Metacycline Sales by Type (2020-2025)
6.3 APAC Metacycline Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Metacycline by Country
  7.1.1 Europe Metacycline Sales by Country (2020-2025)
  7.1.2 Europe Metacycline Revenue by Country (2020-2025)
7.2 Europe Metacycline Sales by Type (2020-2025)
7.3 Europe Metacycline Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Metacycline by Country
  8.1.1 Middle East & Africa Metacycline Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Metacycline Revenue by Country (2020-2025)
8.2 Middle East & Africa Metacycline Sales by Type (2020-2025)
8.3 Middle East & Africa Metacycline Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Metacycline
10.3 Manufacturing Process Analysis of Metacycline
10.4 Industry Chain Structure of Metacycline

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Metacycline Distributors
11.3 Metacycline Customer

12 WORLD FORECAST REVIEW FOR METACYCLINE BY GEOGRAPHIC REGION

12.1 Global Metacycline Market Size Forecast by Region
  12.1.1 Global Metacycline Forecast by Region (2026-2031)
  12.1.2 Global Metacycline Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Metacycline Forecast by Type (2026-2031)
12.7 Global Metacycline Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Merck
  13.1.1 Merck Company Information
  13.1.2 Merck Metacycline Product Portfolios and Specifications
  13.1.3 Merck Metacycline Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Merck Main Business Overview
  13.1.5 Merck Latest Developments
13.2 Boc Sciences
  13.2.1 Boc Sciences Company Information
  13.2.2 Boc Sciences Metacycline Product Portfolios and Specifications
  13.2.3 Boc Sciences Metacycline Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Boc Sciences Main Business Overview
  13.2.5 Boc Sciences Latest Developments
13.3 Manus Aktteva Biopharma
  13.3.1 Manus Aktteva Biopharma Company Information
  13.3.2 Manus Aktteva Biopharma Metacycline Product Portfolios and Specifications
  13.3.3 Manus Aktteva Biopharma Metacycline Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Manus Aktteva Biopharma Main Business Overview
  13.3.5 Manus Aktteva Biopharma Latest Developments
13.4 Cayman Chemical
  13.4.1 Cayman Chemical Company Information
  13.4.2 Cayman Chemical Metacycline Product Portfolios and Specifications
  13.4.3 Cayman Chemical Metacycline Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Cayman Chemical Main Business Overview
  13.4.5 Cayman Chemical Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Metacycline Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Metacycline Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Chronic Bronchitis
Table 4. Major Players of Rickettsial Infections
Table 5. Major Players of Others
Table 6. Global Metacycline Sales by Type (2020-2025) & (MT)
Table 7. Global Metacycline Sales Market Share by Type (2020-2025)
Table 8. Global Metacycline Revenue by Type (2020-2025) & ($ million)
Table 9. Global Metacycline Revenue Market Share by Type (2020-2025)
Table 10. Global Metacycline Sale Price by Type (2020-2025) & (USD/Kg)
Table 11. Global Metacycline Sale by Application (2020-2025) & (MT)
Table 12. Global Metacycline Sale Market Share by Application (2020-2025)
Table 13. Global Metacycline Revenue by Application (2020-2025) & ($ million)
Table 14. Global Metacycline Revenue Market Share by Application (2020-2025)
Table 15. Global Metacycline Sale Price by Application (2020-2025) & (USD/Kg)
Table 16. Global Metacycline Sales by Company (2020-2025) & (MT)
Table 17. Global Metacycline Sales Market Share by Company (2020-2025)
Table 18. Global Metacycline Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Metacycline Revenue Market Share by Company (2020-2025)
Table 20. Global Metacycline Sale Price by Company (2020-2025) & (USD/Kg)
Table 21. Key Manufacturers Metacycline Producing Area Distribution and Sales Area
Table 22. Players Metacycline Products Offered
Table 23. Metacycline Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Metacycline Sales by Geographic Region (2020-2025) & (MT)
Table 27. Global Metacycline Sales Market Share Geographic Region (2020-2025)
Table 28. Global Metacycline Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Metacycline Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Metacycline Sales by Country/Region (2020-2025) & (MT)
Table 31. Global Metacycline Sales Market Share by Country/Region (2020-2025)
Table 32. Global Metacycline Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Metacycline Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Metacycline Sales by Country (2020-2025) & (MT)
Table 35. Americas Metacycline Sales Market Share by Country (2020-2025)
Table 36. Americas Metacycline Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Metacycline Sales by Type (2020-2025) & (MT)
Table 38. Americas Metacycline Sales by Application (2020-2025) & (MT)
Table 39. APAC Metacycline Sales by Region (2020-2025) & (MT)
Table 40. APAC Metacycline Sales Market Share by Region (2020-2025)
Table 41. APAC Metacycline Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Metacycline Sales by Type (2020-2025) & (MT)
Table 43. APAC Metacycline Sales by Application (2020-2025) & (MT)
Table 44. Europe Metacycline Sales by Country (2020-2025) & (MT)
Table 45. Europe Metacycline Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Metacycline Sales by Type (2020-2025) & (MT)
Table 47. Europe Metacycline Sales by Application (2020-2025) & (MT)
Table 48. Middle East & Africa Metacycline Sales by Country (2020-2025) & (MT)
Table 49. Middle East & Africa Metacycline Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Metacycline Sales by Type (2020-2025) & (MT)
Table 51. Middle East & Africa Metacycline Sales by Application (2020-2025) & (MT)
Table 52. Key Market Drivers & Growth Opportunities of Metacycline
Table 53. Key Market Challenges & Risks of Metacycline
Table 54. Key Industry Trends of Metacycline
Table 55. Metacycline Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Metacycline Distributors List
Table 58. Metacycline Customer List
Table 59. Global Metacycline Sales Forecast by Region (2026-2031) & (MT)
Table 60. Global Metacycline Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Metacycline Sales Forecast by Country (2026-2031) & (MT)
Table 62. Americas Metacycline Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Metacycline Sales Forecast by Region (2026-2031) & (MT)
Table 64. APAC Metacycline Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Metacycline Sales Forecast by Country (2026-2031) & (MT)
Table 66. Europe Metacycline Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Metacycline Sales Forecast by Country (2026-2031) & (MT)
Table 68. Middle East & Africa Metacycline Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Metacycline Sales Forecast by Type (2026-2031) & (MT)
Table 70. Global Metacycline Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Metacycline Sales Forecast by Application (2026-2031) & (MT)
Table 72. Global Metacycline Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Merck Basic Information, Metacycline Manufacturing Base, Sales Area and Its Competitors
Table 74. Merck Metacycline Product Portfolios and Specifications
Table 75. Merck Metacycline Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 76. Merck Main Business
Table 77. Merck Latest Developments
Table 78. Boc Sciences Basic Information, Metacycline Manufacturing Base, Sales Area and Its Competitors
Table 79. Boc Sciences Metacycline Product Portfolios and Specifications
Table 80. Boc Sciences Metacycline Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 81. Boc Sciences Main Business
Table 82. Boc Sciences Latest Developments
Table 83. Manus Aktteva Biopharma Basic Information, Metacycline Manufacturing Base, Sales Area and Its Competitors
Table 84. Manus Aktteva Biopharma Metacycline Product Portfolios and Specifications
Table 85. Manus Aktteva Biopharma Metacycline Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 86. Manus Aktteva Biopharma Main Business
Table 87. Manus Aktteva Biopharma Latest Developments
Table 88. Cayman Chemical Basic Information, Metacycline Manufacturing Base, Sales Area and Its Competitors
Table 89. Cayman Chemical Metacycline Product Portfolios and Specifications
Table 90. Cayman Chemical Metacycline Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 91. Cayman Chemical Main Business
Table 92. Cayman Chemical Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Metacycline
Figure 2. Metacycline Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Metacycline Sales Growth Rate 2020-2031 (MT)
Figure 7. Global Metacycline Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Metacycline Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Metacycline Sales Market Share by Country/Region (2024)
Figure 10. Metacycline Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Chronic Bronchitis
Figure 12. Product Picture of Rickettsial Infections
Figure 13. Product Picture of Others
Figure 14. Global Metacycline Sales Market Share by Type in 2025
Figure 15. Global Metacycline Revenue Market Share by Type (2020-2025)
Figure 16. Metacycline Consumed in Clinics
Figure 17. Global Metacycline Market: Clinics (2020-2025) & (MT)
Figure 18. Metacycline Consumed in Hospitals
Figure 19. Global Metacycline Market: Hospitals (2020-2025) & (MT)
Figure 20. Global Metacycline Sale Market Share by Application (2024)
Figure 21. Global Metacycline Revenue Market Share by Application in 2025
Figure 22. Metacycline Sales by Company in 2025 (MT)
Figure 23. Global Metacycline Sales Market Share by Company in 2025
Figure 24. Metacycline Revenue by Company in 2025 ($ millions)
Figure 25. Global Metacycline Revenue Market Share by Company in 2025
Figure 26. Global Metacycline Sales Market Share by Geographic Region (2020-2025)
Figure 27. Global Metacycline Revenue Market Share by Geographic Region in 2025
Figure 28. Americas Metacycline Sales 2020-2025 (MT)
Figure 29. Americas Metacycline Revenue 2020-2025 ($ millions)
Figure 30. APAC Metacycline Sales 2020-2025 (MT)
Figure 31. APAC Metacycline Revenue 2020-2025 ($ millions)
Figure 32. Europe Metacycline Sales 2020-2025 (MT)
Figure 33. Europe Metacycline Revenue 2020-2025 ($ millions)
Figure 34. Middle East & Africa Metacycline Sales 2020-2025 (MT)
Figure 35. Middle East & Africa Metacycline Revenue 2020-2025 ($ millions)
Figure 36. Americas Metacycline Sales Market Share by Country in 2025
Figure 37. Americas Metacycline Revenue Market Share by Country (2020-2025)
Figure 38. Americas Metacycline Sales Market Share by Type (2020-2025)
Figure 39. Americas Metacycline Sales Market Share by Application (2020-2025)
Figure 40. United States Metacycline Revenue Growth 2020-2025 ($ millions)
Figure 41. Canada Metacycline Revenue Growth 2020-2025 ($ millions)
Figure 42. Mexico Metacycline Revenue Growth 2020-2025 ($ millions)
Figure 43. Brazil Metacycline Revenue Growth 2020-2025 ($ millions)
Figure 44. APAC Metacycline Sales Market Share by Region in 2025
Figure 45. APAC Metacycline Revenue Market Share by Region (2020-2025)
Figure 46. APAC Metacycline Sales Market Share by Type (2020-2025)
Figure 47. APAC Metacycline Sales Market Share by Application (2020-2025)
Figure 48. China Metacycline Revenue Growth 2020-2025 ($ millions)
Figure 49. Japan Metacycline Revenue Growth 2020-2025 ($ millions)
Figure 50. South Korea Metacycline Revenue Growth 2020-2025 ($ millions)
Figure 51. Southeast Asia Metacycline Revenue Growth 2020-2025 ($ millions)
Figure 52. India Metacycline Revenue Growth 2020-2025 ($ millions)
Figure 53. Australia Metacycline Revenue Growth 2020-2025 ($ millions)
Figure 54. China Taiwan Metacycline Revenue Growth 2020-2025 ($ millions)
Figure 55. Europe Metacycline Sales Market Share by Country in 2025
Figure 56. Europe Metacycline Revenue Market Share by Country (2020-2025)
Figure 57. Europe Metacycline Sales Market Share by Type (2020-2025)
Figure 58. Europe Metacycline Sales Market Share by Application (2020-2025)
Figure 59. Germany Metacycline Revenue Growth 2020-2025 ($ millions)
Figure 60. France Metacycline Revenue Growth 2020-2025 ($ millions)
Figure 61. UK Metacycline Revenue Growth 2020-2025 ($ millions)
Figure 62. Italy Metacycline Revenue Growth 2020-2025 ($ millions)
Figure 63. Russia Metacycline Revenue Growth 2020-2025 ($ millions)
Figure 64. Middle East & Africa Metacycline Sales Market Share by Country (2020-2025)
Figure 65. Middle East & Africa Metacycline Sales Market Share by Type (2020-2025)
Figure 66. Middle East & Africa Metacycline Sales Market Share by Application (2020-2025)
Figure 67. Egypt Metacycline Revenue Growth 2020-2025 ($ millions)
Figure 68. South Africa Metacycline Revenue Growth 2020-2025 ($ millions)
Figure 69. Israel Metacycline Revenue Growth 2020-2025 ($ millions)
Figure 70. Turkey Metacycline Revenue Growth 2020-2025 ($ millions)
Figure 71. GCC Countries Metacycline Revenue Growth 2020-2025 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Metacycline in 2025
Figure 73. Manufacturing Process Analysis of Metacycline
Figure 74. Industry Chain Structure of Metacycline
Figure 75. Channels of Distribution
Figure 76. Global Metacycline Sales Market Forecast by Region (2026-2031)
Figure 77. Global Metacycline Revenue Market Share Forecast by Region (2026-2031)
Figure 78. Global Metacycline Sales Market Share Forecast by Type (2026-2031)
Figure 79. Global Metacycline Revenue Market Share Forecast by Type (2026-2031)
Figure 80. Global Metacycline Sales Market Share Forecast by Application (2026-2031)
Figure 81. Global Metacycline Revenue Market Share Forecast by Application (2026-2031)